The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China
First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI)
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
he financing was significantly oversubscribed with high demand from both existing and new investors.
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
US $ 555,000 invested by Wavemaker Partners in pre-seed round
Subscribe To Our Newsletter & Stay Updated
